MRKR
Marker Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.18
−4.84%Margins
Gross margin
-320.8%
EBITDA margin
-707.5%
EBIT margin
-869.0%
Net margin
-706.2%
FCF margin
-791.3%
-71.6%
Return on equity
-59.7%
Return on assets
-88.1%
Return on invested capital
0.08x
Asset turnover
-$9.8M
Cash from operations
$0.68
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026